Evidence for two molecular steps in the pathogenesis of myeloid disorders associated with deletion of chromosome 7 long arm

Leukemia

Volumn 11, Issue 12, 1997, Pages 2097-2104

  Kiuru Kuhlefelt, S ^a   Kristo, P ^a   Ruutu, T ^b   Knuutila, S ^a   Kere, J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

7q, loss of heterozygosity; Leukemia; Myelodysplastic syndromes

Indexed keywords

MICROSATELLITE DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CARCINOGENESIS; CELL LINEAGE; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MITOSIS; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031438577     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400881     Document Type: Article

References (19)

1. Sandberg AA. The Chromosomes In Human Cancer and Leukemia. Elsevier: New York, 1990.
2. Mitelman F. Catalog of Chromosome Aberrations in Cancer, 4th edn. Wiley-Liss: New York, 1991.
3. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps on hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromos Cancer 1993; 8: 205-218.
4. Johansson B, Mertens F, Heim S, Kristoffersson U, Mitelman F. Cytogenetics of secondary myelodysplasia (sMDS) and acute non-lymphocytic leukemia (sAML). Eur J Haematol 1991; 47: 17-27.
5. Heim S. Cytogenetic findings in primary and secondary MDS. Leukemia Res 1992; 16: 43-46.
6. Fischer K, Fröhling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui LC, Lichter P, Döhner H. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 1997; 86: 2036-2041.
7. Le Beau MM, Espinosa R, Davis EM, Eisenbart JD, Larson RA, Green ED. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid disorders. Blood 1996; 88: 1930-1935.
8. Johnson EJ, Scherer W, Osborne L, Tsui LC, Oscier D, Mould S, Cotter FE. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 1996; 87: 3579-3586.
9. Bloomfield CD, de la Chapelle A. Chromosome abnormalities in acute nonlymphocytic leukemia: clinical and biologic significance. Semin Oncol 1987; 14: 372-383.
10. Neuman WL, Rubin CM, Rios RB, Larson LA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood 1992; 79: 1501-1510.
11. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes Nos 5 and 7. J Clin Oncol 1986; 4: 325-345.
12. Pedersen B, Ellegaard J. A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genet Cytogenet 1994; 78: 181-188.
13. Rodrigues E, Velloso P, Michaux L, Ferrant A, Hernandez JM, Meeus P, Dierlamm J, Criel A, Louwagie A, Verhoef G, Boogaerts M, Michaux J-L, Bosly A, Mecucci C, Van den Berghe H. Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br J Haematol 1996; 92: 574-581.
14. Biéche I, Champéme MH, Matifas F, Hacéne K, Callahan R, Lidereau R. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 1992; 339: 139-143.
15. Griffin CA, Lazar S, Hamilton SR, Giardiello FM, Long P, Krush AJ, Booker SV, Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas. Cancer Genet Cytogenet 1993; 67: 14-20.
16. Zenklusen JC, Biéche I, Lidereau R, Conti CJ. CA microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 1994; 91: 12155-12158.
17. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 1994; 54: 6370-6373.
18. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R. Allelotype of colorectal carcinomas. Science 1989; 244: 207-211.
19. Zenklusen JC, Thompson JC, Klein-Szanto AJP, Conti CJ. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 1995; 55: 1347-1350.